About Bigfoot Biomedical
Bigfoot Biomedical is a Healthcare company based in Milpitas (United States) founded in 2014, and was acquired by Abbott in September 2023. Developer of a closed-loop automated insulin delivery system. Bigfoot Biomedical has raised $214.51 million across 11 funding rounds from investors including Abbott, Janus Henderson Investors and Senvest Capital. The company has 133 employees. Bigfoot Biomedical has completed 2 acquisitions, including Asante Solutions and Timesulin. Bigfoot Biomedical offers products and services including Bigfoot Unity System. Its focus areas include Life Sciences, Diabetes, Medical Devices and Monitoring Devices. Its legal entity is Bigfoot Biomedical, Inc. Its competitors include Livongo, Senseonics and One Drop; 3 of its 3 listed competitors have raised funding.
Company details
Bigfoot Biomedical was founded in 2014 and is based in Milpitas, United States. Operations focus on the biomedical sector, where a closed-loop insulin delivery system is created. This system integrates an insulin pump from Asante, a Bluetooth-enabled controller, and continuous glucose monitoring from Dexcom. An algorithm is employed to regulate insulin release based on real-time data, supporting diabetes management.
- Headquarters Milpitas, United States
- Employees 133
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website bigfootbiomedical.com
- Social LinkedIn X Facebook
- Acquired by Abbott (Sep 2023)
- Legal Name Bigfoot Biomedical, Inc
- Total Equity Funding$214.51M (USD)
in 11 rounds
- InvestorsAbbott
& 11 more
- Employee Count133
- Investments & AcquisitionsAsante Solutions
& 1 more
- Acquired byAbbott
(Sep 2023)
Products & Services of Bigfoot Biomedical
Bigfoot Biomedical offers a comprehensive portfolio of products and services, including Bigfoot Unity System.
Offers real-time insulin dose recommendations using glucose data.
Funding Insights of Bigfoot Biomedical
Bigfoot Biomedical has successfully raised a total of $214.51M across 11 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $214.51M
- Total Rounds 11
- Investors Count 12
Latest 10 of 11 funding rounds of Bigfoot Biomedical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2021 | Debt – Conventional | – | – | ||
| Mar 2021 | $57M | Series C | – | Madryn Asset Management | – |
| Jun 2020 | $55M | Series C | – | Abbott | |
| Mar 2018 | $18M | Series B | – | Abbott | |
| Dec 2017 | $37.13M | Series B | – | Janus Henderson Investors, Quadrant Capital Advisors | |
| Jan 2017 | Series A | – | T1D Fund | – | |
| Oct 2016 | $35.5M | Series A | – | Janus Henderson Investors | |
| Jan 2016 | $2.38M | Series A | – | – | – |
| Aug 2015 | $6.5M | Series A | – | – | – |
| May 2015 | $3M | Series A | – | – | – |
12 investors in total: 12 institutional.
Investors in Bigfoot Biomedical
Bigfoot Biomedical has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include Abbott, Janus Henderson Investors and Senvest Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| quadrantcapital.com | ||||
Multiple sectors are invested in by this private equity firm. | 1999 | senvest.com | New York, United States | |
Multiple sectors are targeted for venture capital investments. | 1934 | janushenderson.com | London, United Kingdom | |
Smile Group is engaged in investing, building, and partnering with disruptive founders across Asia. | smile.group | Gurugram, India | ||
Global tech startups are invested in stage-agnostically by Visionnaire Ventures. | visionnaire.vc | San Francisco, United States | ||
Multiple sectors are invested in by the private equity firm. | qcai.com | New York, United States | ||
Companies developing T1D products are funded through venture philanthropy. | t1dfund.org | Boston, United States | ||
Diversified asset management is provided by the firm. | 2017 | madrynlp.com | New York, United States | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | abbott.com | Libertyville, United States | |
Diversified investment management is conducted by ICV in New York. | 2014 | icvgroup.org | New York, United States |
Investor details for Bigfoot Biomedical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Bigfoot Biomedical
1328 people are tracked at Bigfoot Biomedical (535 in leadership, 13 in board & advisors, 780 in team); the tracked headcount is 133.
| Name | Role | Group |
|---|---|---|
Esther Chagoya | Director Strategic Initiatives And Communications | Leadership |
Juan Manuel Fonseca Saravia | General Manager | Leadership |
Charles Craig | Director Cybersecurity Services | Leadership |
Trevor Burlison | Area Vice President | Leadership |
Diana Luo | Divisional Vice President, Commercial Legal, Structural Heart And Heart Failure | Leadership |
Eric Ryan | Director, Adult Global Marketing | Leadership |
Hoai Trinh | Regional HR Director | Leadership |
Lauren White | Director Of Cybersecurity | Leadership |
Christian Moormann | Head of Product Development | Leadership |
Meghan Griffin | Global Clinical Program Director | Leadership |
Alexa Bisinger | Area Medical Director - Americas | Leadership |
Vahe Ayvazian | Divisional Vice President Global Diagnostics | Leadership |
Karen Rodriguez | Division Vice President Operations, Rapid Diagnostics | Leadership |
Ding | Chief Cybersecurity Architect | Leadership |
Vildan Kehr | Divisional Vice President, Human Resources, Rapid And Molecular Diagnostics | Leadership |
Ramon Neira | Division VP and Controller, Emerging Markets, Infectious Diseases, Rapid Diagnostics | Leadership |
Darshan Gada | Regional Finance Director - Abbott India | Leadership |
Dr. Ursula Christian | R&d Divisional Vice President Product Development, Hematology | Leadership |
Linda Wang | General Manager, Dvp, Epd, Abbott China | Leadership |
Charmaine Goh | HR Business Partner (on Contract) | Leadership |
1308 more people are available in the full profile.
Complete people profiles for Bigfoot Biomedical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bigfoot Biomedical
Bigfoot Biomedical has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Asante Solutions and Timesulin.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Replacement cap for Insulin pens to enhance Medication adherence | timesulin.com | London, United Kingdom | 2010 | Jun 2017 | •••• | |
Insulin pump systems are developed and customized by Asante Solutions. | snappump.com | Sunnyvale, United States | 2006 | May 2015 | •••• |
Complete acquisition details for Bigfoot Biomedical
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Bigfoot Biomedical
6 dated milestones of Bigfoot Biomedical across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Bigfoot Biomedical is founded.
- Funding First funding round.
- Acquisition Acquires Asante Solutions.
- Acquisition Acquires Timesulin.
- Funding Latest funding round, Debt – Conventional,.
- Exit Acquired by Abbott.
Competitors of Bigfoot Biomedical
Bigfoot Biomedical has 3 listed competitors in our database, 3 of them funded. They include Livongo, Senseonics and One Drop.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| livongo.com | 2014 | San Francisco, United States | $237M | 3,263 | Provider of smart devices for diabetes management for patients and doctors | |
| senseonics.com | 1996 | Germantown, United States | $175.46M | 132 | Implantable continuous glucose monitoring systems are provided for diabetes management. | |
| onedrop.today | 2015 | New York, United States | $107.87M | 166 | Provider of workforce healthcare solutions |
Detailed competitors of Bigfoot Biomedical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Bigfoot Biomedical
The website of Bigfoot Biomedical (bigfootbiomedical.com) receives about 2.3K visits a month.
- Monthly visits2.3K
▲ 39% vs previous month
Top companies in Diabetes
3 companies that operate in the same segment as Bigfoot Biomedical (Diabetes) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bigfoot Biomedical
Complete news archive for Bigfoot Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bigfoot Biomedical
Bigfoot Biomedical was founded in 2014.
Bigfoot Biomedical is headquartered in Milpitas, United States. It is registered at Milpitas, California, United States.
Bigfoot Biomedical is a funded company, having raised a total of $214.51M across 11 funding rounds to date. The company's 1st funding round was a Series A of $3M, raised on Jun 2014.
Bigfoot Biomedical has 133 employees.
Bigfoot Biomedical was founded in 2014 and is based in Milpitas, United States. Operations focus on the biomedical sector, where a closed-loop insulin delivery system is created. This system integrates an insulin pump from Asante, a Bluetooth-enabled controller, and continuous glucose monitoring from Dexcom. An algorithm is employed to regulate insulin release based on real-time data, supporting diabetes management.
Bigfoot Biomedical's top competitors include Senseonics, One Drop and Livongo.
Bigfoot Biomedical offers Bigfoot Unity System.
Bigfoot Biomedical has made 2 acquisitions, including Asante Solutions, and Timesulin.
Bigfoot Biomedical has 12 investors. Key investors include Abbott, Janus Henderson Investors, Senvest Capital, Madryn Asset Management, and Conscious Capital.
Bigfoot Biomedical operates through Bigfoot Biomedical, Inc.
Yes. Bigfoot Biomedical was acquired by Abbott in September 2023.